In the world of assisted reproduction, the quest for higher IVF success rates is an ongoing journey. While many aspects of the process have seen remarkable advancements, one critical step remains largely unchanged: embryo transfer. This is despite the fact that it is the final and most vulnerable stage, with only a third of transfers resulting in pregnancy. The question then arises: are we missing out on potential improvements by sticking to traditional methods? A recent Cochrane review has shed light on this, revealing that common embryo transfer techniques, such as adjusting bladder fullness and removing cervical mucus, do not provide clear evidence of benefit. This finding is particularly intriguing, as it challenges the notion that these practices are universally beneficial. In my opinion, this highlights a critical issue in the field of reproductive medicine: the reliance on tradition and local protocols over robust, high-quality evidence. Dr. Ryosuke Akino, an obstetrician-gynaecologist, echoes this sentiment, stating that current practices often reflect historical convention rather than strong, high-quality evidence. This raises a deeper question: why do we continue to use methods that have not been rigorously tested, especially when the consequences are so significant? One possible explanation is the difficulty in standardizing embryo transfer procedures. Unlike other aspects of IVF, which have seen significant advancements, this particular step is highly dependent on the person performing the procedure, making large, rigorous trials challenging to design. Additionally, the potential risks associated with these techniques, such as discomfort and procedural factors, may deter women from participating in randomized trials. However, this does not mean that we should abandon the pursuit of improvement. On the contrary, it emphasizes the need for more robust, better-quality trials. As Dr. Noyuri Yamaji from Showa Medical University, Japan, points out, these small changes and techniques could potentially make a massive difference. But, as the Cochrane review suggests, we need to prioritize research in resource-limited settings, where basic procedural standardization could matter more than advanced technical modifications. This raises an important consideration: the role of cost and accessibility in the development of new IVF techniques. While most aspects of IVF have advanced considerably over the past few decades, this particular step has remained largely unchanged. This is despite the fact that it is the final and most vulnerable stage, with only a third of transfers resulting in pregnancy. The question then arises: are we missing out on potential improvements by sticking to traditional methods? In my view, the answer is a resounding yes. We need to challenge the status quo and explore new avenues for improving IVF success rates. This includes investing in research in resource-limited settings, where basic procedural standardization could have a significant impact. Ultimately, the goal should be to provide the best possible care for couples struggling with infertility. This requires a commitment to evidence-based practice and a willingness to challenge traditional methods. Only then can we hope to make significant strides in the field of assisted reproduction.
